share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  08/01 15:37
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 5,295 shares of common stock on 08/01/2024, with an aggregate market value of $2,689,860. The shares were originally acquired on the same date through an option granted on 06/01/2017 from the issuer. The transaction will be conducted in cash. This follows a previous sale of 7,073 shares in the past three months, which grossed $3,168,704.
Vertex Pharmaceuticals Inc. Director, Bruce I. Sachs, is set to sell 5,295 shares of common stock on 08/01/2024, with an aggregate market value of $2,689,860. The shares were originally acquired on the same date through an option granted on 06/01/2017 from the issuer. The transaction will be conducted in cash. This follows a previous sale of 7,073 shares in the past three months, which grossed $3,168,704.
Vertex Pharmaceuticals Inc.董事Bruce I. Sachs将于2024年08月01日卖出5295股普通股,市值为2689860美元。这些股票原本是通过2017年06月01日发放的期权获得的。此次交易将以现金方式进行。此前三个月曾经卖出7073股,总共获得3168704美元。
Vertex Pharmaceuticals Inc.董事Bruce I. Sachs将于2024年08月01日卖出5295股普通股,市值为2689860美元。这些股票原本是通过2017年06月01日发放的期权获得的。此次交易将以现金方式进行。此前三个月曾经卖出7073股,总共获得3168704美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息